Detalhe da pesquisa
1.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Blood
; 136(13): 1499-1506, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603426
2.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
3.
Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.
Blood
; 131(25): 2782-2788, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618479
4.
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
Am J Hematol
; 95(1): 48-56, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637757
5.
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.
Haematologica
; 104(6): 1221-1229, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630975
6.
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
Haematologica
; 104(2): 380-391, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262560
7.
Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.
Biol Blood Marrow Transplant
; 24(2): 308-313, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032276
8.
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.
Haematologica
; 108(11): 3148-3151, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021537
9.
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(3): 405-411, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28007665
10.
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant
; 22(9): 1582-1587, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27311969
11.
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
Biol Blood Marrow Transplant
; 22(2): 380-385, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26348890
12.
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Cancer
; 121(20): 3709-16, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26207349
13.
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
Br J Haematol
; 171(5): 788-97, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26455717
14.
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Blood
; 119(11): 2675-8, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308289
15.
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Blood
; 119(11): 2657-64, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234678
16.
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
Haematologica
; 99(10): 1624-31, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085357
17.
Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol.
PLoS One
; 19(5): e0302970, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728244
18.
Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.
Biol Blood Marrow Transplant
; 19(9): 1340-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23769990
19.
Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 19(9): 1403-6, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871782
20.
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
Biomark Res
; 11(1): 31, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927800